Hemanext Announces Close of Series B3 Equity Financing Round

Hemanext Announces Close of Series B3 Equity Financing Round

Hemanext Inc., a leading innovator in blood processing, storage and transfusion technology, announced the close of its Series B-3 equity financing round. The round raised $18.9 million at a post-money valuation of $172 million or $0.275 per share, with support from new investors and repeat investments from those participating in the Series B-2 capital round. Lexington, MA July 22, 2025 --(PR.com)-- Hemanext Inc., a leading innovator in blood pro…